Oncopharmpod

Small Cell Lung Cancer: Established & Recent Advances

Informações:

Synopsis

Small cell lung cancer is reviewed, including the milestone advances (chemo + RT, omitting surgery, cis/etoposide) of the past leading up to the latest advance (15:20) - FDA-approval of nivolumab in the 3rd-line setting.